cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

Breast Cancer Research and Treatment

Volumn 96, Issue 1, 2006, Pages 17-39

  Villeneuve, David J ^a   Hembruff, Stacey L ^a   Veitch, Zachary ^b   Cecchetto, Melanie ^a   Dew, William A ^b   Parissenti, Amadeo M ^a,b,c  

^a SUDBURY REGIONAL HOSPITAL   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Doxorubicin; Drug resistance; Genetic signatures; MCF 7; Microarray analysis; Paclitaxel; Pathways; Q PCR

Indexed keywords

ADRIAMYCIN PFS; COMPLEMENTARY DNA; DOXORUBICIN; PACLITAXEL;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN MCF 7; CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DRUG SPECIFICITY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33645232498     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9026-6     Document Type: Article

References (215)

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, van de Eisen MB, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001
2. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Gokden M, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Pecorelli S Jr.: Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling. Br J Cancer 90: 1814-1824, 2004
3. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T: Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 18: 63-71, 2004
4. van't Veer LJ, Dai H., van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der KK, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002
5. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L., van, d V, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002
6. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63: 1602-1607, 2003
7. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Richards WG, Jaklitsch MT, Sugarbaker DJ, Bueno R: Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 95: 598-605, 2003
8. Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M: Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 12(2): R153-R157, 2003
9. Yu K, Lee CH, Tan PH, Hong GS, Wee SB, Wong CY, Tan P: A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res 64: 2962-2968, 2004
10. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P: Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362: 362-369, 2003
11. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, Lecocke M, Metivier J, Booser D, Ibrahim N, Valero V, Royce M, Arun B, Whitman G, Ross J, Sneige N, Hortobagyi GN, Pusztai L: Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22: 2284-2293, 2004
12. Iwao-Koizumi K, Matoba R, Ueno N, Kim SJ, Ando A, Miyoshi Y, Maeda E, Noguchi S, Kato K: Prediction of docetaxel response in human breast cancer by gene expression profiling. J Clin Oncol 23: 422-431, 2005
13. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, Kimura Y, Kubo K, Yagasaki F, Higa T, Taguchi H, Tobita T, Akiyama H, Takeshita A, Wang YH, Motoji T, Ohno R, Nakamura Y: Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther 1: 1035-1042, 2002
14. Zijlstra JG, de Jong S, de Vries EG, Mulder NH: Topoisomerases, new targets in cancer chemotherapy. Med Oncol Tumor Pharmacother 7: 11-18, 1990
15. Capranico G, De IP, Penco S, Tinelli S, Zunino F: Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6- deoxydoxorubicin in murine leukemia P388 cells. Cancer Res 49: 2022-2027, 1989
16. Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O: Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. Cancer Res 60: 2912-2918, 2000
17. Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H: Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 32: 881-889, 2000
18. Chazard M, Pellae-Cosset B, Garet F, Soares JA, Lucidi B, Lavail Y, Lenaz L: [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes]. Bull Cancer 81: 173-181, 1994
19. Arioka H, Saijo N: Microtubules and antineoplastic drugs. Gan To Kagaku Ryoho 21: 583-590, 1994
20. Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Panici PB, Mancuso S: Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. Int J Cancer 72: 844-850, 1997
21. Moos PJ, Fitzpatrick FA: Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci USA 95: 3896-3901, 1998
22. Berg CD, Swain SM: Results of concomitantly administered chemoradiation for locally advanced noninflammatory breast cancer. Semin Radiat Oncol 4: 226-235, 1994
23. Ueno NT, Buzdar AU, Singletary SE, Ames FC, McNeese MD, Holmes FA, Theriault RL, Strom EA, Wasaff BJ, Asmar L, Frye D, Hortobagyi GN: Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M.D. Anderson Cancer Center. Cancer Chemother Pharmacol 40: 321-329, 1997
24. Crown J.: Nonanthracycline containing docetaxel-based combinations in metastatic breast cancer. Oncologist 6(3): 17-21, 2001
25. Guo B, Villeneuve DJ, Hembruff SL, Kirwan AF, Blais DE, Bonin M, Parissenti AM: Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure. Breast Cancer Res Treat 85: 31-51, 2004
26. Chadderton A, Villeneuve DJ, Gluck S, Kirwan-rhude AF, Gannon BR, Blais DE, Parissenti AM: Role of specific apoptotic pathways in the restoration of paclitaxel- induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells. Breast Cancer Res Treat 59: 231-244, 2000
27. Keating A, Toor P: Human Long Term Bone Marrow Culture. In: Poclard JM (ed) p. 331. Wiley-Liss, New York, 1990
28. Villeneuve DJ, Parissenti AM: The use of DNA microarrays to investigate the pharmacogenomics of drug response in living systems. Curr Top Med Chem 4: 1329-1345, 2004
29. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R: Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270: 10618-10624, 1995
30. Hendy GN, Bennett HP, Gibbs BF, Lazure C, Day R, Seidah NG: Proparathyroid hormone is preferentially cleaved to parathyroid hormone by the prohormone convertase furin. A mass spectrometric study. J Biol Chem 270: 9517-9525, 1995
31. Khatib AM, Siegfried G, Prat A, Luis J, Chretien M, Metrakos P, Seidah NG: Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 276: 30686-30693, 2001
32. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
33. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369, 1993
34. Kim SY, Berger D, Yim SO, Sacks PG, Tainsky MA: Coordinate control of growth and cytokeratin 13 expression by retinoic acid. Mol Carcinog 16: 6-11, 1996
35. Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H: Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 438-443, 1998
36. Rosenberger G, Grusci M, Fuhrmann G, Leuhuber K, Polgar D, Krupitza G: Transferrin ensures survival of ovarian carcinoma cells subjected to deferoxamine, TNFα, FasL, TRAIL or MYC-Activation. Sci World J 1: 93, 2001
37. Fonseca AM, Pereira CF, Porto G, Arosa FA: Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress. Free Radic Biol Med 35: 1404-1416, 2003
38. Albuquerque KV, Price MR, Badley RA, Jonrup I, Pearson D, Blamey RW, Robertson JF: Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol 21: 504-509, 1995
39. Yang DC, Wang F, Elliott RL, Head JF: Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res 21: 541-549, 2001
40. Fan W, Christensen M, Eichler E, Zhang X, Lennon G: Cloning, sequencing, gene organization, and localization of the human ribosomal protein RPL23A gene. Genomics 46: 234-239, 1997
41. Pool MR, Stumm J, Fulga TA, Sinning I, Dobberstein B: Distinct modes of signal recognition particle interaction with the ribosome. Science 297: 1345-1348, 2002
42. Lai CF, Feng X, Nishimura R, Teitelbaum SL, Avioli LV, Ross FP, Cheng SL: Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 275: 36400-36406, 2000
43. Liang Y, Meleady P, Cleary I, McDonnell S, Connolly L, Clynes M: Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur J Cancer 37: 1041-1052, 2001
44. Morazzani M, de Carvalho DD, Kovacic H, Smida-Rezgui S, Briand C, Penel C: Monolayer versus aggregate balance in survival process for EGF-induced apoptosis in A431 carcinoma cells: implication of ROS-P38 MAPK-integrin alpha2beta1 pathway. Int J Cancer 110: 788-799, 2004
45. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML: Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279: 24015-24023, 2004
46. Lindberg FP, Lublin DM, Telen MJ, Veile RA, Miller YE, Donis-Keller H, Brown EJ: Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem 269: 1567-1570, 1994
47. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr.: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380, 1994
48. Bell AC, West AG, Felsenfeld G: The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98: 387-396, 1999
49. Bell AC, Felsenfeld G: Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405: 482-485, 2000
50. Murakami A, Yajima T, Sakuma H, McLaren MJ, Inana G: X-arrestin: a new retinal arrestin mapping to the X chromosome. FEBS Lett 334: 203-209, 1993
51. Sakuma H, Murakami A, Fujimaki T, Inana G: Isolation and characterization of the human X-arrestin gene. Gene 224: 87-95, 1998
52. Revankar CM, Vines CM, Cimino DF, Prossnitz ER: Arrestins Block G Protein-coupled Receptor-mediated Apoptosis. J Biol Chem 279: 24578-24584, 2004
53. Marie M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, Cresswell P: Defective antigen processing in GILT-free mice. Science 294: 1361-1365, 2001
54. Arunachalam B, Phan UT, Geuze HJ, Cresswell P: Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA 97: 745-750, 2000
55. Fu M, Zhu X, Zhang J, Liang J, Lin Y, Zhao L, Ehrengruber MU: Chen YE Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 315: 33-41, 2003
56. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162, 1976
57. Kartner N, Shales M, Riordan JR, Ling V: Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res 43: 4413-4419, 1983
58. Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288, 1983
59. Emery P, Durand B, Mach B, Reith W: RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucl Acids Res 24: 803-807, 1996
60. Villard J, Reith W, Barras E, Gos A, Morris MA, Antonarakis SE, Van den Elsen PJ, Mach B: Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum Mutat 10: 430-435, 1997
61. Worwood M, Brook JD, Cragg SJ, Hellkuhl B, Jones BM, Perera P, Roberts SH, Shaw DJ: Assignment of human ferritin genes to chromosomes 11 and 19q13.3-19qter. Hum Genet 69: 371-374, 1985
62. Rich BE, Steitz JA: Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol Cell Biol 7: 4065-4074, 1987
63. Tchorzewski M, Krokowski D, Rzeski W, Issinger OG, Grankowski N: The subcellular distribution of the human ribosomal "stalk" components: P1, P2 and P0 proteins. Int J Biochem Cell Biol 35: 203-211, 2003
64. Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, Vannais D, Patterson D: Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 53: 220-233, 1993
65. Wang K, Ramji S, Bhathena A, Lee C, Riddick DS: Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines. Xenobiotica 29: 155-170, 1999
66. Park JS, Yamamoto W, Sekikawa T, Matsukawa M, Okamoto R, Sasaki M, Ukon K, Tanimoto K, Kumazaki T, Nishiyama M: Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers. Int J Oncol 20: 333-338, 2002
67. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001
68. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W: Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425: 307-311, 2003
69. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, Butcher EC: Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 107: 595-601, 2001
70. Qin KN, New MI, Cheng KC: Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 46: 673-679, 1993
71. Burczynski ME, Lin HK, Penning TM: Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 59: 607-614, 1999
72. Callahan HL, Beverley SM: A member of the aldoketo reductase family confers methotrexate resistance in Leishmania. J Biol Chem 267: 24165-24168, 1992
73. Karin M, Richards RI: Human metallothionein genes-primary structure of the metallothionein-II gene and a related processed gene. Nature 299: 797-802, 1982
74. Schmidt CJ, Hamer DH, McBride OW: Chromosomal location of human metallothionein genes: implications for Menkes' disease. Science 224: 1104-1106, 1984
75. Cui Y, Wang J, Zhang X, Lang R, Bi M, Quo L, Lu SH: ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A, links to apoptosis. Biochem Biophys Res Commun 302: 904-915, 2003
76. Becker T, Gerke V, Kube E, Weber K: S100P, a novel Ca(2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem 207: 541-547, 1992
77. Jin G, Wang S, Hu X, Jing Z, Chen J, Ying K, Xie Y, Mao Y: Characterization of the tissue-specific expression of the s100P gene whichencodes an EF-hand Ca2+-binding protein. Mol Biol Rep 30: 243-248, 2003
78. Kusumegi T, Tanaka J, Kawano M, Yonemoto J, Tohyama C, Sone H.: BMP7/ActRIIB regulates estrogen-dependent apoptosis: new biomarkers for environmental estrogens. J Biochem Mol Toxicol 18: 1-11, 2004
79. Baade RT, Utne HR, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, Sundan A, Borset M: Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 23: 3024-3032, 2004
80. Krisans SK, Ericsson J, Edwards PA, Keller GA: Farnesyl-diphosphate synthase is localized in peroxisomes. J Biol Chem 269: 14165-14169, 1994
81. Pandit J, Danley DE, Schulte GK, Mazzalupo S, Pauly TA, Hayward CM, Hamanaka ES, Thompson JF, Harwood HJ Jr: Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis. J Biol Chem 275: 30610-30617, 2000
82. Ribieras S, Tomasetto C, Rio MC: The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta 1378: F61-F77, 1998
83. Roberts M, Wallace J, Jeltsch JM, Berry M: The 5′ flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells. Biochem Biophys Res Commun 151: 306-313, 1988
84. Morrison BW, Moorman JR, Kowdley GC, Kobayashi YM, Jones LR, Leder P: Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem 270: 2176-2182, 1995
85. Sweadner KJ, Rael E: The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68: 41-56, 2000
86. Lublin DM, Liszewski MK, Post TW, Arce MA, Le Beau MM, Rebentisch MB, Lemons LS, Seya T, Atkinson JP: Molecular cloning and chromosomal localization of human membrane co-factor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med 168: 181-194, 1988
87. Bomstein Y, Fishelson Z: Enhanced sensitivity of P-glycoprotein-positive multidrug resistant tumor cells to complement-mediated lysis. Eur J Immunol 27: 2204-2211, 1997
88. Glenney JR, Soppet D Jr.: Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89: 10517-10521, 1992
89. Fiucci G, Ravid D, Reich R, Liscovitch M: Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21: 2365-2375, 2002
90. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, Lisanti MP: Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 273: 20448-20455, 1998
91. Sagara Y, Mimori K, Yoshinaga K, Tanaka F, Nishida K, Ohno S, Inoue H, Mori M: Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. Br J Cancer 91: 959-965, 2004
92. Couet J, Sargiacomo M, Lisanti MP: Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272: 30429-30438, 1997
93. Gurel V, Sens DA, Somji S, Garrett SH, Nath J, Sens MA: Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells. Breast Cancer Res Treat 80: 181-191, 2003
94. Miller KG, Sollner-Webb B.: Transcription of mouse rRNA genes by RNA polymerase I: in vitro and in vivo initiation and processing sites. Cell 27: 165-174, 1981
95. Beck WT, Danks MK: Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Semin Cancer Biol 2: 235-244, 1991
96. Zheng X, Chou PM, Mirkin BL, Rebbaa A: Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res 64: 1773-1780, 2004
97. Chauhan SS, Liang XJ, Su AW, Pai-Panandiker A, Shen DW, Hanover JA, Gottesman MM: Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer 88: 1327-1334, 2003
98. Devarajan E, Chen J, Multani AS, Pathak S, Sahin AA, Mehta K: Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features. Int J Oncol 20: 913-920, 2002
99. Hembruff SL, Villeneuve DJ, Parissenti AM: The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data. Anal Biochem 345: 237-249, 2005
100. Tewari M, Yu M, Ross B, Dean C, Giordano A, Rubin R: AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res 57: 4063-4069, 1997
101. Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H, Bugler B: FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol 14: 1709-1724, 2000
102. Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U: Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat Genet 18: 237-242, 1998
103. Muntasell A, Carrascal M, Serradell L, Veelen PP, Verreck F, Koning F, Raposo G, Abian J, Jaraquemada D: HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J Immunol 169: 5052-5060, 2002
104. Nong Y, Kandil O, Tobin EH, Rose RM, Remold HG: The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR, cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1. Cell Immunol 132: 10-16, 1991
105. Dorak MT, Folayan GO, Niwas S, van Leeuwen DJ, Yee LJ, Tang J, Kaslow RA: C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection. Immunol Res 26: 167-175, 2002
106. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V: Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817-819, 1985
107. Ino T, Yasui H, Hirano M, Kurosawa Y: Identification of a member of the TIS11 early response gene family at the insertion point of a DNA fragment containing a gene for the T-cell receptor beta chain in an acute T-cell leukemia. Oncogene 11: 2705-2710, 1995
108. Nie XF, Maclean KN, Kumar V, McKay IA, Bustin SA: ERF-2, the human homologue of the murine Tis11d early response gene. Gene 152: 285-286, 1995
109. Sollner T, Griffiths G, Pfaller R, Pfanner N, Neupert W: MOM19, an import receptor for mitochondrial precursor proteins. Cell 59: 1061-1070, 1989
110. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47, 2002
111. Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M: Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood 100: 3710-3718, 2002
112. Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ: Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90: 7884-7888, 1993
113. McCabe NR, Burnett RC, Gill HJ, Thirman MJ, Mbangkollo D, Kipiniak M, van Melle E, der Ziemin-van Poel S, Rowley JD, Diaz MO: Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 89: 11794-11798, 1992
114. Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T: Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol Cell Biol 11: 4088-4096, 1991
115. Aoki M, Hamada F, Sugimoto T, Sumida S, Akiyama T, Toyoshima K: The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J Biol Chem 268: 22723-22732, 1993
116. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604, 1987
117. Todd JA: Genetic control of autoimmunity in type 1 diabetes. Immunol Today 11: 122-129, 1990
118. Tafani M, Schneider TG, Pastorino JG, Farber JL: Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition. Am J Pathol 156: 2111-2121, 2000
119. Tafani M, Minchenko DA, Serroni A, Farber JL: Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res 61: 2459-2466, 2001
120. Jiang XC, Masucci-Magoulas L, Mar J, Lin M, Walsh A, Breslow JL, Tall A: Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. J Biol Chem 268: 27406-27412, 1993
121. Kasai K, Akagawa K: Roles of the cytoplasmic and transmembrane domains of syntaxins in intracellular localization and trafficking. J Cell Sci 114: 3115-3124, 2001
122. Horwitz J: The function of alpha-crystallin in vision. Semin Cell Dev Biol 11: 53-60, 2000
123. Mehlen P, Schulze-Osthoff K, Arrigo AP: Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271: 16510-16514, 1996
124. Mehlen P, Preville X, Chareyron P, Briolay J, Klemenz R, Arrigo AP: Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 154: 363-374, 1995
125. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP: Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J 15: 2695-2706, 1996
126. Andley UP, Song Z, Wawrousek EF, Brady JP, Bassnett S, Fleming TP: Lens epithelial cells derived from alphaB-crystallin knockout mice demonstrate hyperproliferation and genomic instability. FASEB J 15: 221-229, 2001
127. Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahani S, Nomura T, Raz A, Kubo T: Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol 18: 787-792, 2001
128. Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S: Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 85: 545-554, 2000
129. Moon BK, Lee YJ, Battle P, Jessup JM, Raz A, Kim HR: Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am J Pathol 159: 1055-1060, 2001
130. Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A: Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57: 5272-5276, 1997
131. Schedin P, Mitrenga T, Kaeck M: Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 5: 211-225, 2000
132. Miyake H, Hara S, Zellweger T, Kamidono S, Gleave ME, Hara I: Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells. Mol Urol 5: 105-111, 2001
133. Casero RA Jr., Celano P, Ervin SJ, Applegren NB, Wiest L, Pegg AE: Isolation and characterization of a cDNA clone that codes for human spermidine/spermine N1-acetyltransferase. J Biol Chem 266: 810-814, 1991
134. Xiao L, Casero RA Jr: Differential transcription of the human spermidine/spermine N1-acetyltransferase (SSAT) gene in human lung carcinoma cells. Biochem J 313(Pt 2): 691-696, 1996
135. Tomitori H, Nenoi M, Mita K, Daino K, Igarashi K, Ichimura S.: Functional characterization of the human spermidine/spermine N(1)-acetyltransferase gene promoter. Biochim Biophys Acta 1579: 180-184, 2002
136. Patterson AV, Barham HM, Chinje EC, Adams GE, Harris AL, Stratford IJ: Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233). Br J Cancer 72: 1144-1150, 1995
137. Shephard EA, Phillips IR, Santisteban I, West LF, Palmer CN, Ashworth A, Povey S: Isolation of a human cytochrome P-450 reductase cDNA clone and localization of the corresponding gene to chromosome 7q11.2. Ann Hum Genet 53(Pt 4): 291-301, 1989
138. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, Igarashi K: Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK, regulate transcription through the NF-E2 site. Mol Cell Biol 16: 6083-6095, 1996
139. Ohira M, Seki N, Nagase T, Ishikawa K, Nomura N, Ohara O: Characterization of a human homolog (BACH1) of the mouse Bach1 gene encoding a BTB-basic leucine zipper transcription factor and its mapping to chromosome 21q22.1. Genomics 47: 300-306, 1998
140. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B: Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 272: 3628-3634, 1997
141. Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG, Esteller M: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62: 4519-4524, 2002
142. Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El Deiry WS, Tsichlis PN: The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 18: 2462-2473, 1998
143. Rodel B, Wagner T, Zornig M, Messing J, Moroy T: The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34 13-A locus frequently altered in hematopoietic diseases. Genomics 54: 580-582, 1998
144. Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, Deutsch U, Klein R: EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell 9: 725-737, 2002
145. L'Allemain G: Involvement of ephrins and their receptors in oncogenesis. Bull Cancer 87: 529-530, 2000
146. Yatouji S, Trussardi-Regnier A, Trentesaux C, Liautaud-Roger F, Dufer J: Nuclear texture and chromatin structure in OV1/VCR human multidrug-resistant cell line. Int J Oncol 23: 1225-1230, 2003
147. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA: Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-16903, 2002
148. Ryseck RP, Macdonald-Bravo H, Mattei MG, Bravo R: Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts. Exp Cell Res 180: 266-275, 1989
149. Colombat M, Paradis V, Bieche I, Dargere D, Laurendeau I, Belghiti J, Vidaud M, Degott C, Bedossa P: Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. J Pathol 201: 260-267, 2003
150. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, Milbrandt J, Deuel TF: Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250: 1690-1694, 1990
151. Travali S, Ku DH, Rizzo MG, Ottavio L, Baserga R, Calabretta B: Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 264: 7466-7472, 1989
152. Bravo R: Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163: 287-293, 1986
153. Wilde CD, Chow LT, Wefald FC, Cowan NJ: Structure of two human alpha-tubulin genes. Proc Natl Acad Sci USA 79: 96-100, 1982
154. Banerjee A: Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun 293: 598-601, 2002
155. Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR: Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer 77: 562-566, 1998
156. Sullivan KF, Cleveland DW: Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proc Natl Acad Sci USA 83: 4327-4331, 1986
157. Rimokh R, Gadoux M, Bertheas MF, Berger F, Garoscio M, Deleage G, Germain D, Magaud JP: FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. Blood 81: 136-142, 1993
158. Roy SN, Horwitz SB: A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res 45: 3856-3863, 1985
159. Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP: Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr: 55-61, 1993
160. Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintenig GM, Sepulveda FV: Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32, 1992
161. Hardy SP, Valverde MA, Goodfellow HR, Higgins CF, Sepulveda FV: Regulation of volume activated chloride channels by protein kinase C- mediated phosphorylation of P-glycoprotein. Jpn J Physiol 44(2): S9-15, 1994
162. Hasmann M, Valet GK, Tapiero H, Trevorrow K, Lampidis T: Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry. Biochem Pharmacol 38: 305-312, 1989
163. Belhoussine R, Morjani H, Gillet R, Palissot V, Manfait M: Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells. Adv Exp Med Biol 457: 365-381, 1999
164. Hoffman MM, Wei LY, Roepe PD: Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?. J Gen Physiol 108: 295-313, 1996
165. Spalletti-Cernia D, D'Agnano I, Sorrentino R, Zupi G, Vecchio G, Portella G, Laccetti P: Verapamil reverts resistance to drug-induced apoptosis in Ki-ras-transformed cells by altering the cell membrane and the mitochondrial transmembrane potentials. Oncol Res 13: 25-35, 2002
166. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15665-15670, 1998
167. Hayes JD, Pulford DJ: The glutathione S-transferase supergene family: regulation of GST, the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995
168. Chun E, Lee KY: Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 315: 771-779, 2004
169. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA: Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J 9: 33-41, 2003
170. Zuckerman R, Cheasty JE: A 48 kDa protein arrests cGMP phosphodiesterase activation in retinal rod disk membranes. FEBS Lett 207: 35-41, 1986
171. Wang Q, Zhao J, Brady AE, Feng J, Allen PB, Lefkowitz RJ, Greengard P, Limbird LE: Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 304: 1940-1944, 2004
172. Shimizu N, Soda Y, Kanbe K, Liu HY, Mukai R, Kitamura T, Hoshino H: A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J Virol 74: 619-626, 2000
173. Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV: G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol 169: 5546-5554, 2002
174. Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, Hung MC: Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459-469, 2004
175. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De SE, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G: Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542, 2004
176. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G: NF-kappaB JNK: An Intricate Affair. Cell Cycle 3: 2004
177. Yang DC, Jiang X, Elliott RL, Head JF: Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells. Anticancer Res 22: 1513-1524, 2002
178. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK: Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 63: 5390-5400, 2003
179. Aoudjit F, Vuori K: Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 20: 4995-5004, 2001
180. Maubant S, Staedel C, Gauduchon P: [Integrins, cell response to anti-tumor agents and chemoresistance]. Bull Cancer 89: 923-934, 2002
181. Bathori G, Cervenak L, Karadi I: Caveolae - an alternative endocytotic pathway for targeted drug delivery. Crit Rev Ther Drug Carrier Syst 21: 67-95, 2004
182. Cai C, Chen J: Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells. Int J Cancer 111: 522-529, 2004
183. Uyemura K, Uyemura K: Functional glycoproteins expressed in Schwann cell membrane. Neurosci Res 16: 9-13, 1993
184. Schiemann S, Ruckels M, Engelholm LH, Schwirzke M, Brunner N, Weidle UH: Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family. Anticancer Res 17: 13-20, 1997
185. Kunz-Schughart LA, Heyder P, Schroeder J, Knuechel R: A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp Cell Res 266: 74-86, 2001
186. Williams GR, Wright NA: Trefoil factor family domain peptides. Virchows Arch 431: 299-304, 1997
187. Millot C, Millot JM, Morjani H, Desplaces A, Manfait M: Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry. J Histochem Cytochem 45: 1255-1264, 1997
188. Ouar Z, Bens M, Vignes C, Paulais M, Pringel C, Fleury J, Cluzeaud F, Lacave R, Vandewalle A: Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Biochem J 370: 185-193, 2003
189. Klohs WD, Steinkampf RW: The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol Pharmacol 34: 180-185, 1988
190. Andley UP, Song Z, Wawrousek EF, Fleming TP, Bassnett S: Differential protective activity of alpha A- and alphaB-crystallin in lens epithelial cells. J Biol Chem 275: 36823-36831, 2000
191. Liu JP, Schlosser R, Ma WY, Dong Z, Feng H, Lui L, Huang XQ, Liu Y, Li DW: Human alphaA-, alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK AKT signaling pathways. Exp Eye Res 79: 393-403, 2004
192. Kamradt MC, Lu M, Werner ME, Kwan T, Chen F, Strohecker A, Oshita S, Wilkinson JC, Yu C, Oliver PG, Duckett CS, Buchsbaum DJ, Lobuglio AF, Jordan VC, Cryns VL: The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem. 2005
193. Kamradt MC, Chen F, Cryns VL: The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem 276: 16059-16063, 2001
194. Mao YW, Liu JP, Xiang H, Li DW: Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ 11: 512-526, 2004
195. Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE: alphaB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer 100: 2543-2548, 2004
196. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, Parry S, Budroni M, Palmieri G, Neville AM, O'Hare MJ, Lakhani SR: Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 64: 3037-3045, 2004
197. Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK: Overexpression of clusterin in human breast carcinoma. Am J Pathol 157: 393-399, 2000
198. Miyake H, Hara I, Kamidono S, Gleave ME, Eto H: Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol Rep 10: 469-473, 2003
199. Biroccio A, D'Angelo C, Jansen B, Gleave ME, Zupi G: Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab. J Cell Physiol, 2005
200. July LV, Beraldi E, So A, Fazli L, Evans K, English JC, Gleave ME: Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer Ther 3: 223-232, 2004
201. Miyake H, Chi KN, Gleave ME: Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res 6: 1655-1663, 2000
202. Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH: Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP cIAP1 in situ. J Biol Chem 277: 44236-44243, 2002
203. Floros KV, Thomadaki H, Katsaros N, Talieri M, Scorilas A: mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem 385: 1099-1103, 2004
204. Bian X, Giordano TD, Lin HJ, Solomon G, Castle VP, Opipari AW Jr: Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation. J Biol Chem 279: 4663-4669, 2004
205. Cui H, Schroering A, Ding HF: p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 1: 679-686, 2002
206. Varelias A, Koblar SA, Cowled PA, Carter CD, Clayer M: Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer 95: 862-869, 2002
207. Weissbach H, Brot N.: Regulation of methionine synthesis in Escherichia coli. Mol Microbiol 5: 1593-1597, 1991
208. Chen Y, Vujcic S, Liang P, Diegelman P, Kramer DL, Porter CW: Genomic identification and biochemical characterization of a second spermidine/spermine N1-acetyltransferase. Biochem J 373: 661-667, 2003
209. Kanezaki R, Toki T, Yokoyama M, Yomogida K, Sugiyama K, Yamamoto M, Igarashi K, Ito E: Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform. J Biol Chem 276: 7278-7284, 2001
210. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, Shibahara S: Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003
211. Hoffman RM: Altered methionine metabolism and transmethylation in cancer. Anticancer Res 5: 1-30, 1985
212. Cabot MC, Giuliano AE, Han TY, Liu YY: SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res 59: 880-885, 1999
213. Cabot MC, Han TY, Giuliano AE: The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett 431: 185-188, 1998
214. Bezombes C, Maestre N, Laurent G, Levade T, Bettaieb A, Jaffrezou JP: Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J 12: 101-109, 1998
215. Ganapathi R, Grabowski D, Schmidt H, Bell D, Melia M: Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells. Cancer Res 47: 3464-3468, 1987